JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3997
CAS [1425381-60-7]
MF C24H28N8O2MW 460.53
ASN-002 is a orally available potent dual inhibitor of SYK (Spleen Tyrosine Kinase) and pan-JAK (Janus kinases) with IC50 values of 5-46 nM in biochemical assays. In mechanistic cell-based studies involving IgE and cytokine stimulations, ASN002 strongly suppressed the SYK and JAK family kinase signaling pathways measured as pLAT and pSTAT levels, respectively. The compound showed anti-proliferative activity in a broad panel of human cancer cell lines including DHL6, DHL4, OCI-LY10, H929, Pfeiffer, HT-1376, and Lovo, suggesting activity in both solid and hematological tumor types. In a multiple myeloma (H929) xenograft model, ASN002 exhibited significant efficacy in inhibiting tumor growth (>95%). It also significantly delayed the onset of hind limb paralysis in the human erythroleukemia (HEL) mouse model.
KEYWORDS: ASN-002 | Supplier | SYK and JAK inhibitor | Gusacitinib | ASN002 | ASN 002 | CT-ASN002 | CAS [1425381-60-7] | B-Cell transformation | Spleen tyrosine kinase (Syk) | JAK | Inhibitor | Enzymes
2-(1-(4-(4-(4-Hydroxypiperidin-1-yl)phenylamino)-5-oxo-5,6-dihydropyrimido[5,4-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile
[1425381-60-7]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields